N-[3-[(2-acetamidothiazol-4-yl)methyl]-5-[2-[(2E)-2-benzylidenehydrazino]-2-oxo-ethyl]sulfanyl-1,2,4-triazol-4-yl]-4-chloro-benzamide

InChIKey	`SLKSRHOPMDATBX-RPPGKUMJSA-N`
Compound Name	N-[3-[(2-acetamidothiazol-4-yl)methyl]-5-[2-[(2E)-2-benzylidenehydrazino]-2-oxo-ethyl]sulfanyl-1,2,4-triazol-4-yl]-4-chloro-benzamide
Canonical SMILES	`CC(=O)Nc1nc(Cc2nnc(SCC(=O)N/N=C/c3ccccc3)n2NC(=O)c2ccc(Cl)cc2)cs1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	6.78
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q00535	CDK5	Homo sapiens	Human	PF00069	7.5	IC50	ChEMBL
Q15078	CDK5R1	Homo sapiens	Human	PF03261	7.5	IC50	ChEMBL
O96020	CCNE2	Homo sapiens	Human	PF02984 PF00134	6.3	IC50	ChEMBL
P24864	CCNE1	Homo sapiens	Human	PF02984 PF00134	6.3	IC50	ChEMBL
P24941	CDK2	Homo sapiens	Human	PF00069	6.3	IC50	ChEMBL